Home » Stocks » INMD

InMode Ltd. (INMD)

Stock Price: $60.70 USD -0.17 (-0.28%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
Pre-market: $60.00 -0.70 (-1.15%) Jan 27, 8:40 AM
Market Cap 1.99B
Revenue (ttm) 177.92M
Net Income (ttm) 57.95M
Shares Out 36.70M
EPS (ttm) 1.16
PE Ratio 52.37
Forward PE 28.49
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $60.70
Previous Close $60.87
Change ($) -0.17
Change (%) -0.28%
Day's Open 61.07
Day's Range 60.27 - 62.20
Day's Volume 429,254
52-Week Range 14.86 - 62.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 2 weeks ago

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: AZRE, HEES, KEP, MLI
PRNewsWire - 3 weeks ago

YOQNEAM, Israel, Jan. 6, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced it will present a corporate social responsibil...

Seeking Alpha - 3 weeks ago

InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite trea...

Zacks Investment Research - 1 month ago

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Other stocks mentioned: FCAU, MCRI, NPO, PIPR
Zacks Investment Research - 1 month ago

Is (INMD) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 month ago

InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research - 2 months ago

Is (INMD) Outperforming Other Medical Stocks This Year?

Seeking Alpha - 2 months ago

InMode has seen a tough first and second quarter for obvious reasons, yet remained incredibly profitable. Net cash balances never put the viability of the company in doubt as valuations were f...

Seeking Alpha - 2 months ago

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

YOKNEAM, Israel, Nov. 12, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial resul...

Zacks Investment Research - 2 months ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and...

Other stocks mentioned: CBIO, CSTL, UFPI, VRSN
Zacks Investment Research - 2 months ago

Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.

Other stocks mentioned: EXAS, QQQ, VCEL, XLK
PRNewsWire - 2 months ago

YOKNEAM, Israel, Nov. 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chi...

Zacks Investment Research - 2 months ago

Find Strong Stocks with this New Analyst Coverage Screener

Other stocks mentioned: GRBK
Zacks Investment Research - 3 months ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Perion (PERI), Live Oak (LOB), LexinFintech (LX) and InMode (INMD).

Other stocks mentioned: LOB, LX, PERI
PRNewsWire - 3 months ago

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market th...

The Motley Fool - 3 months ago

The cosmetic device maker's sales rebounded sharply in the third quarter.

The Motley Fool - 3 months ago

These three health-related businesses are well positioned to provide market-beating gains.

Other stocks mentioned: COLL, PFE
Zacks Investment Research - 4 months ago

InMode is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

The Motley Fool - 4 months ago

The medical device maker announced a million-share repurchase program.

InvestorPlace - 5 months ago

Growth stocks have been the market's biggest winners. Amid valuation concerns, these 10 stocks still have the potential for 100%-plus gains.

Other stocks mentioned: APHA, CRWD, FSLY, PGNY, PINS, REAL, ROKU, SPCE, WORK
Seeking Alpha - 5 months ago

InMode went public in August, 2019, raising $70 million.

PRNewsWire - 5 months ago

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd.

Seeking Alpha - 5 months ago

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

YOKNEAM, Israel, Aug. 5, 2020 /PRNewswire/ -- InMode Ltd.

PRNewsWire - 5 months ago

YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ -- InMode Ltd.

PRNewsWire - 6 months ago

LAKE FOREST, Calif., July 27, 2020 /PRNewswire/ -- InMode Ltd.

Zacks Investment Research - 6 months ago

InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

The Motley Fool - 6 months ago

The medical device maker's boosting its second-quarter guidance.

Zacks Investment Research - 6 months ago

InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.

Zacks Investment Research - 7 months ago

InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.

Zacks Investment Research - 7 months ago

In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.

Seeking Alpha - 7 months ago

InMode: A Look Into The Fundamentals Reveals A Clear Undervaluation

Seeking Alpha - 8 months ago

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q1 2020 Results - Earnings Call Transcript

InvestorPlace - 8 months ago

These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.

Other stocks mentioned: CDLX, HCAT, INSG, LPSN, MAXR, NIO, PLUG, SFIX, TRHC
Zacks Investment Research - 8 months ago

InMode's (INMD) Q1 performance is likely to have been driven by developments in business segments amid coronavirus-led supply disruptions.

The Motley Fool - 8 months ago

Some high-growth names in the beauty and fashion industries are trading at a discount.

Other stocks mentioned: FTCH, SDC
Zacks Investment Research - 9 months ago

Profitability analysis is one of the best ways to evaluate the prospects of a company.

Other stocks mentioned: BCOR, DHT, ENPH
Zacks Investment Research - 9 months ago

Here are 5 ways to make the most of a difficult market.

Other stocks mentioned: CAH, DVA, ENSG, ITGR
Zacks Investment Research - 9 months ago

The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.

Other stocks mentioned: AQN, AWR, GO, REGN, USFD
Zacks Investment Research - 11 months ago

Bull of the Day: InMode Ltd. (INMD)

Seeking Alpha - 11 months ago

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q4 2019 Results - Earnings Call Transcript

Investors Business Daily - 11 months ago

Stocks Weather Apple News: RH Breaks Out, PAAS Nears Buy, InMode Dives

Stocks solid despite Apple: RH breaks out, Pan American Silver nears buy, InMode dives.

Other stocks mentioned: RH, PAAS
Zacks Investment Research - 11 months ago

InMode (INMD) closed at $44.14 in the latest trading session, marking a -0.07% move from the prior day.

Zacks Investment Research - 11 months ago

InMode's (INMD) Q4 performance is likely to have been driven by developments in business segments.

Zacks Investment Research - 11 months ago

InMode (INMD) closed the most recent trading day at $42.81, moving -0.23% from the previous trading session.

Seeking Alpha - 11 months ago

InMode's BodyTite Procedure Is Less Attractive Than Investors Assume

InvestorPlace - 1 year ago

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semi were our top stock trades for Friday -- and here's why.

Other stocks mentioned: MSFT, SIG, TNDM, TSM
ETF Trends - 1 year ago

Karuna Therapeutics, NextCure, and Cortexyme aren’t household names when it comes to investors looking at initial public offerings (IPOs), but they’ve been generating big-time returns for inve...

Other stocks mentioned: BYND, CRTX, IGMS, KRTX, NXTC, PLMR, SWAV, TPTX
The Motley Fool - 1 year ago

Incredibly, they're almost all health stocks, including 7 biotechs, an eye surgery platform, and a medical device company.

Other stocks mentioned: APLT, APRE, BNTX, GKOS, KRTX, NXTC, PLMR, RAPT, TPTX

About INMD

InMode designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of pr... [Read more...]

Industry
Medical Devices
IPO Date
Aug 8, 2019
CEO
Moshe Mizrahy
Employees
251
Stock Exchange
NASDAQ
Ticker Symbol
INMD
Full Company Profile

Financial Performance

In 2019, InMode's revenue was $156.36 million, an increase of 56.11% compared to the previous year's $100.16 million. Earnings were $61.15 million, an increase of 173.32%.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for InMode stock is "Strong Buy." The 12-month stock price forecast is 63.67, which is an increase of 4.89% from the latest price.

Price Target
$63.67
(4.89% upside)
Analyst Consensus: Strong Buy